THERMO FISHER SCIENTIFIC INC.Underwriting Agreement • March 8th, 2017 • Thermo Fisher Scientific Inc. • Measuring & controlling devices, nec • New York
Introductory. Thermo Fisher Scientific Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A hereto (the “Underwriters”), acting severally and not jointly, the respective amounts set forth in such Schedule A of €500,000,000 aggregate principal amount of the Company’s 1.450% Senior Notes due 2027 (the “Notes”). Credit Suisse Securities (Europe) Limited and HSBC Bank plc have agreed to act as lead managers of the several Underwriters (in such capacity, the “Lead Managers”) in connection with the offering and sale of the Notes.
